NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...
The company said that the sale of its medical device testing business would allow it to focus on core areas of preclinical drug development and chemical testing.
Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback